concept

MICROGLIAL SENESCENCE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MICROGLIAL SENESCENCE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

37Connections

15Hypotheses

6Analyses

17Outgoing

20Incoming

6Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	MICROGLIAL SENESCENCE

Pathway Diagram

graph TD
    MICROGLIAL_SENESCENCE[MICROGLIAL SENESCENCE]
    MICROGLIAL_SENESCENCE -->|involved_in| Neurodegenerative_Disease[Neurodegenerative Disease]
    MICROGLIAL_SENESCENCE -->|contributes to| Aging_Related_Neurodegenerativ[Aging-Related Neurodegenerative Disease Pathogenesis]
    MICROGLIAL_SENESCENCE -->|contributes to| Neurodegeneration_Progression[Neurodegeneration Progression]
    MICROGLIAL_SENESCENCE -->|contributes to| Neurodegeneration[Neurodegeneration]
    MICROGLIAL_SENESCENCE -->|causes (creates a feed-forward loop of neuroinflammation l)| neurodegeneration_vulnerabilit[neurodegeneration vulnerability]
    MICROGLIAL_SENESCENCE -->|suppresses| phagocytosis_capacity[phagocytosis capacity]
    CGAS[CGAS] -->|involved_in| MICROGLIAL_SENESCENCE
    cGAS_STING_pathway_activation[cGAS-STING pathway activation] -->|causes (age-related activation of cGAS-STING drives microg)| MICROGLIAL_SENESCENCE
    Apoe4[Apoe4] -->|upregulates| MICROGLIAL_SENESCENCE
    TREM2[TREM2] -->|modulates| MICROGLIAL_SENESCENCE

Outgoing (17)

Target	Relation	Type	Str
IL-6	causes	protein	0.90
TNF-α	causes	protein	0.90
ALS progression	associated_with	disease	0.90
SASP	causes	phenotype	0.90
SASP	activates	process	0.90
neuroinflammation	causes	phenotype	0.90
neurodegeneration vulnerability	causes (creates a feed-forward loop of neuroinflammation l)	disease	0.85
Neurodegenerative Disease	involved_in	disease	0.85
Aging-Related Neurodegenerative Disease Pathogenesis	contributes_to	mechanism	0.85
Neurodegeneration Progression	contributes_to	process	0.85
Neuroinflammation	associated_with	process	0.85
Neurodegeneration	contributes_to	process	0.85
Neurodegenerative Disease	risk_factor_for	disease	0.85
phagocytosis capacity	suppresses	process	0.80
CXCL1	causes	protein	0.70
Mitochondrial dysfunction	causes	mechanism	0.70
amyloid-beta accumulation	causes	phenotype	0.70

Incoming (20)

Source	Relation	Type	Str
CHIT1/CHI3L1	biomarker_for	biomarker	0.90
39446353	reduces	paper	0.90
autophagy pathway	inhibits	pathway	0.90
impaired autophagy	causes	process	0.90
Cgas-Sting Pathway	activates	pathway	0.90
cGAS-STING pathway activation	causes (age-related activation of cGAS-STING drives microg)	pathway	0.85
CGAS	involved_in	gene	0.85
Apoe4	upregulates	biomarker	0.80
TREM2	modulates	gene	0.80
NLRP3 Inflammasome	associated_with	pathway	0.80
Aging	associated_with	process	0.80
TFEB	modulates	transcription_factor	0.70
CDKN2A	regulates	gene	0.70
TREM2	causes	gene	0.70
Excess ROS	activates	process	0.70
41892314	associated with	paper	0.60
TBK1	regulates	gene	0.50
lipid metabolism dysregulation	causes	mechanism	0.50
TREM2	associated_with	gene	0.50
TDP-43 pathology	causes	phenotype	0.50

Targeting Hypotheses (15)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc	0.893	neurodegeneration	Gene expression changes in aging mouse b
Microglial Senescence Prevention via TREM2/SASP Axis	0.837	neurodegeneration	Does the cancer-cystatin-C-TREM2 pathway
TREM2 Deficiency Drives Microglial Senescence via Lipid Meta	0.836	neurodegeneration	What molecular mechanisms drive microgli
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes	0.666	neurodegeneration	Gene expression changes in aging mouse b
TREM2-Dependent Microglial Senescence Transition	0.618	neurodegeneration	scRNA-seq Processing and Cell Type Annot

APOE4 Induces Region-Specific Microglial Senescence Driving	0.600	neuroinflammation	How do regional, age, and sex-dependent
CD38 Inhibition for NAD+ Restoration and Microglial Senescen	0.575	neurodegeneration	Microglial subtypes in neurodegeneration
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli	0.555	neurodegeneration	TREM2 in Alzheimer's Disease: Mechanisms
Telomere Attrition and DNA Damage Response Activation Induce	0.520	neurodegeneration	What molecular mechanisms drive microgli
Mitochondrial DNA Damage and cGAS-STING Activation Induces M	0.520	neurodegeneration	What molecular mechanisms drive microgli
TBK1 Loss Drives Microglial Senescence-SASP to Generate MMP-	0.499	als	What are the mechanisms by which microgl
Selective Microglial Senescence Targeting via TREM2 Modulati	0.459	-	Senescent cell clearance as neurodegener
Plasma TREM2 Ectodomain Glycosylation Patterns as Microglial	0.380	biomarkers	What biomarkers can reliably detect micr
Selective Microglial Senescence Targeting via P16INK4A-Guide	0.000	-	Senescent cell clearance as neurodegener
Microglial Senescence Reversal Through TREM2 Agonism	0.000	-	Senolytic therapy for age-related neurod

Mentioning Analyses (6)

Scientific analyses that reference this entity

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.878

Microglial senescence in Alzheimer and Parkinson disease progression

neurodegeneration | 2026-04-26 | 0 hypotheses

What molecular mechanisms drive microglial senescence and the transition to dyst

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.836

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Experiments (6)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	Mouse (5xFAD/TREM2-/-)	in_progress	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.800	Mouse (5xFAD/TREM2-/-)	completed	N/A
TREM2 KO amyloid pathology study	validation	Alzheimers Disease	0.200	Mouse (5xFAD/TREM2-/-)	in_progress	N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214]	Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia	J Inflamm Res	2022	1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818]	Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang	Mech Ageing Dev	2021	1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797]	Zhou Y, Song WM, Andhey PS, Swain A, Lev	Nat Med	2020	1
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038]	Ulland TK, Song WM, Huang SC, Ulrich JD,	Cell	2017	1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663]	Krasemann S, Madore C, Cialic R, Baufeld	Immunity	2017	1
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042]	["Lyu G", "Li D"]	CNS & neurological disorders d	2026	0
Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793]	["Wang R", "Feng Y", "Zhou Z", "Jiang J"	Frontiers in aging neuroscienc	2026	0
Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182]	["Puerta R", "Garc\u00eda-Gonz\u00e1lez	medRxiv : the preprint server	2026	0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907]	Tsai AP, Martin AK, Mi A, Yeh AE, Ramire	Molecular neurodegeneration	2026	0
Opioid-induced transcriptional reprogramming of cerebrospinal fluid immune cells [PMID:41674808]	Acharya A, Ambikan AT, Neogi U, Lamberty	Res Sq	2026	0
Siah2 is a lipid-mediated metabolic sensor in adipose tissue macrophage. [PMID:41690475]	Dang TN, Ghosh B, Panta PR, Taylor JM, K	J Lipid Res	2026	0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907]	Tsai AP, Martin AK, Mi A, Yeh AE, Ramire	Mol Neurodegener	2026	0
TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604]	Yang HC, Deng YS, Zhang J, Zhang T, Song	J Alzheimers Dis	2026	0
Investigating the Potential of Gene Editing Technologies in Enhancing Stem Cell [PMID:41926312]	["Mehrabadi S"]	Current aging science	2026	0
TREM2 in neurodegeneration and diseases. [PMID:41792456]	["Abdulkhaliq A", "Alasiri G", "Kim B",	Molecular psychiatry	2026	0
Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of [PMID:41772384]	["Siew J", "Lee C", "Chen H", "Lin H", "	Brain : a journal of neurology	2026	0
The microglial TREM2 receptor programs hippocampal development in a mouse model [PMID:41887542]	Ahmed S, Bowers C, Munoz-Martin J, Jamwa	Brain, behavior, and immunity	2026	0
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842]	Alhusaini M, Mussa BM, Ilce BY, Alhaj H,	Frontiers in aging neuroscienc	2026	0
Oligodendrocyte precursor cells-microglia crosstalk via BMP4 drives microglial n [PMID:41881962]	Baek S, Jang J, Yeo S, Jung HJ, Choe Y	Signal transduction and target	2026	0
Phagocytes as plaque catalysts: Human macrophages generate seeding-competent Aβ4 [PMID:41770935]	["Konstantoulea K", "Ramakers M", "Borri	Proceedings of the National Ac	2026	0

Debates (20)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

closed · Rounds: 4 · Score: 0.33 · 2026-04-27

Debate: TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysre

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Investigate how microglial senescence drives ALS progression through inflammatio

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

closed · Rounds: 4 · Score: 0.64 · 2026-04-26

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Related Research

Hypotheses and analyses mentioning MICROGLIAL SENESCENCE in their description or question text

APOE4 Induces Region-Specific Microglial Senescence Driving Frontal Cortex Neuro

Score: 0.600 · neuroinflammation · 2026-04-22

## Mechanistic Overview APOE4 Induces Region-Specific Microglial Senescence Driving Frontal Cortex Neurodegeneration sta

CD38 Inhibition for NAD+ Restoration and Microglial Senescence Prevention

Score: 0.575 · neurodegeneration · 2026-04-25

High risk. The Expert identifies a fatal flaw: CD38 is predominantly expressed in peripheral immune cells (B cells, T ce

CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Revers

Score: 0.555 · neurodegeneration · 2026-04-07

## Mechanistic Overview CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal starts from t

Telomere Attrition and DNA Damage Response Activation Induces Microglial Senesce

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Telomere Attrition and DNA Damage Response Activation Induces Microglial Senescence starts from

Mitochondrial DNA Damage and cGAS-STING Activation Induces Microglial Senescence

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Mitochondrial DNA Damage and cGAS-STING Activation Induces Microglial Senescence starts from the

TBK1 Loss Drives Microglial Senescence-SASP to Generate MMP-9-Mediated TDP-43 C-

Score: 0.499 · als · 2026-04-27

This hypothesis proposes that TBK1 loss-of-function mutations initiate a pathological cascade where microglia become loc

Selective Microglial Senescence Targeting via TREM2 Modulation

Score: 0.459 · unknown disease · 2026-04-16

## Mechanistic Overview Selective Microglial Senescence Targeting via TREM2 Modulation starts from the claim that modula

Plasma TREM2 Ectodomain Glycosylation Patterns as Microglial Senescence Biomarke

Score: 0.380 · biomarkers · 2026-04-27

Site-specific glycosylation patterns on circulating TREM2 ectodomain fragments distinguish senescent from activated micr

Selective Microglial Senescence Targeting via P16INK4A-Guided Senolytics

Score: 0.000 · unknown disease · 2026-04-28

Using P16INK4A-targeting nanoparticles loaded with dasatinib+quercetin to selectively eliminate senescent microglia Deb

Microglial Senescence Reversal Through TREM2 Agonism

Score: 0.000 · unknown disease · 2026-04-28

TREM2 agonists will reverse microglial senescence by restoring phagocytic capacity and reducing SASP factor production t

MICROGLIAL SENESCENCE

Understanding Entity Pages

Pathway Diagram

Outgoing (17)

Incoming (20)

Targeting Hypotheses (15)

Mentioning Analyses (6)

TREM2 in Alzheimer's Disease: Mechanisms, Therapeutics, and Biomarkers

What are the mechanisms by which microglial senescence contributes to ALS pathol

Microglial senescence in Alzheimer and Parkinson disease progression

What molecular mechanisms drive microglial senescence and the transition to dyst

Senescent cell clearance as neurodegeneration therapy

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Experiments (6)

Related Papers (20)

Debates (20)

Extended debate: Metabolic Reprogramming to Reverse Senescence

Extended debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegenera

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

Debate: TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysre

Hypothesis debate: TREM2-Mediated Microglial Dysfunction Disrupts Perivascular T

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Investigate how microglial senescence drives ALS progression through inflammatio

Hypothesis debate: TREM2-Dependent Microglial Senescence Transition

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegene

Related Research

APOE4 Induces Region-Specific Microglial Senescence Driving Frontal Cortex Neuro

CD38 Inhibition for NAD+ Restoration and Microglial Senescence Prevention

CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Revers

Telomere Attrition and DNA Damage Response Activation Induces Microglial Senesce

Mitochondrial DNA Damage and cGAS-STING Activation Induces Microglial Senescence

TBK1 Loss Drives Microglial Senescence-SASP to Generate MMP-9-Mediated TDP-43 C-

Selective Microglial Senescence Targeting via TREM2 Modulation

Plasma TREM2 Ectodomain Glycosylation Patterns as Microglial Senescence Biomarke

Selective Microglial Senescence Targeting via P16INK4A-Guided Senolytics

Microglial Senescence Reversal Through TREM2 Agonism